MedTrace Logo

Severe Asthma Covid Vaccine Response Study

NCT05130320 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2021-11-23

No results posted yet for this study

Summary

This study aims to employ a simple finger-prick home test to detect post vaccination antibody levels. The investigators will compare antibody responses in patients with severe asthma on varying treatment regimes (biologics, daily steroids, inhalers-only) with healthy, age-matched controls to study if the magnitude and range of responses vary between severe asthmatics and healthy individuals.

Conditions

  • Coronavirus Antibody Levels

Interventions

OTHER

Not Interventional their treatments are their routine NHS care

Not Interventional their treatments are their routine NHS care

Sponsors & Collaborators

  • Asthma Allergy & Inflammation Research Trust

    collaborator UNKNOWN

  • University Hospital Southampton NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Hitasha Rupani · University Hospital Southampton NHS Foundation Trust

Eligibility

Min Age
16 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-06
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05130320 on ClinicalTrials.gov